Epidemiological and Genetic Aspects of NAFLD and NASH in Mexico
Paulina Vidal‐Cevallos, Aldo Torre, Nahum Mendez‐Sanchez, Misael Uribe, Norberto C. Chavez‐Tapia – 9 March 2022
Hepatocellular Carcinoma in Mexico
Laura Esthela Cisneros Garza, Ignacio Aiza Haddad – 9 March 2022
Viral Kinetics of an Acute Hepatitis B Virus Subgenotype F1b Infection in a Mexican Subject
Arturo Panduro, Sonia Roman, Nora A. Fierro, João R. Rebello‐Pinho – 9 March 2022
Epidemiological and Genetic Aspects of NAFLD and NASH in Mexico
Paulina Vidal‐Cevallos, Aldo Torre, Nahum Mendez‐Sanchez, Misael Uribe, Norberto C. Chavez‐Tapia – 9 March 2022
Nonviral Infections of the Liver in Developing Countries
Mauricio Castillo Barradas, Nayelli Cointa Flores García – 9 March 2022
Hepatocellular Carcinoma in Mexico
Laura Esthela Cisneros Garza, Ignacio Aiza Haddad – 9 March 2022
Hepatocellular Carcinoma in Mexico
Laura Esthela Cisneros Garza, Ignacio Aiza Haddad – 9 March 2022
Making child’s play of tolerance: Defining the immune‐viral interplay during combination entecavir and pegylated interferon therapy for immune‐tolerant hepatitis B infection
Jessica Howell, Margaret Hellard – 8 March 2022
The spectrum of primary liver cancers: heterogeneity and continuity. A foundation for diagnosis and treatment of cancer
Mina Komuta, Akihisa Ueno, Michiie Sakamoto – 8 March 2022
Gut microbiota–derived short‐chain fatty acids regulate group 3 innate lymphoid cells in HCC
Chupeng Hu, Bingqing Xu, Xiaodong Wang, Wen‐Hua Wan, Jinying Lu, Deyuan Kong, Yu Jin, Wenhua You, Hua Sun, Xiaoxin Mu, Dongju Feng, Yun Chen – 8 March 2022